Rockwell Medical (NASDAQ:RMTI) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Rockwell Medical (NASDAQ:RMTI) posted its earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01), Zacks reports. Rockwell Medical had a negative net margin of 2.38% and a negative return on equity of 6.79%. The firm had revenue of $15.93 million for the quarter, compared to the consensus estimate of $16.24 million. Rockwell Medical updated its FY 2025 guidance to EPS.

Rockwell Medical Trading Down 4.5%

RMTI stock traded down $0.04 during midday trading on Thursday, reaching $0.91. The company’s stock had a trading volume of 327,588 shares, compared to its average volume of 627,376. Rockwell Medical has a 1 year low of $0.78 and a 1 year high of $2.67. The firm has a market capitalization of $31.42 million, a price-to-earnings ratio of -15.21 and a beta of 1.68. The stock has a fifty day simple moving average of $1.26 and a two-hundred day simple moving average of $1.13. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.51 and a current ratio of 2.89.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. HC Wainwright decreased their price target on shares of Rockwell Medical from $3.00 to $2.50 and set a “buy” rating on the stock in a research note on Thursday. Weiss Ratings restated a “sell (d-)” rating on shares of Rockwell Medical in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $3.75.

Institutional Trading of Rockwell Medical

An institutional investor recently raised its position in Rockwell Medical stock. Vanguard Group Inc. lifted its position in Rockwell Medical, Inc. (NASDAQ:RMTI) by 12.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,354,147 shares of the company’s stock after purchasing an additional 148,737 shares during the period. Vanguard Group Inc. owned 3.93% of Rockwell Medical worth $1,625,000 at the end of the most recent quarter. Institutional investors own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.